Pacific Biosciences of California Inc PACB:NASDAQ

Last Price$8.28Cboe Real-Time Last Sale as of 2:21PM ET 8/15/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-0.51(5.80%)
Bid (Size)$8.27 (600)
Ask (Size)$8.28 (200)
Day Low / High$8.26 - 9.25
Volume4.1 M

View Biotechnology IndustryPeer Comparison as of 08/15/2022


Pacific Biosciences of California Inc ( NASDAQ )

Price: $8.28
Change: -0.51 (5.80%)
Volume: 4.1 M
2:21PM ET 8/15/2022

Arcus Biosciences Inc ( NYSE )

Price: $27.97
Change: +0.77 (2.83%)
Volume: 186.9 K
2:20PM ET 8/15/2022

Iovance Biotherapeutics Inc ( NASDAQ )

Price: $12.72
Change: +0.06 (0.47%)
Volume: 557.5 K
2:20PM ET 8/15/2022

Krystal Biotech Inc ( NASDAQ )

Price: $77.99
Change: -1.31 (1.65%)
Volume: 30.2 K
2:20PM ET 8/15/2022

Dynavax Technologies Corp ( NASDAQ )

Price: $15.61
Change: -0.73 (4.47%)
Volume: 1.1 M
2:20PM ET 8/15/2022

Read more news Recent News

--Morgan Stanley Lowers Price Target for Pacific Biosciences of California to $10 From $14, Maintains Equalweight Rating
9:28AM ET 8/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Posts Q2 Loss $-0.34
4:15PM ET 8/03/2022 MT Newswires


-- Earnings Flash (PACB) PACIFIC BIOSCIENCES OF CALIFORNIA Reports Q2 Revenue $35.5M
4:14PM ET 8/03/2022 MT Newswires


Pacific Biosciences of California, Invitae Modify Development and Commercial Agreement
7:36AM ET 7/01/2022 MT Newswires

Pacific Biosciences of California (PACB) and Invitae (NVTA) have modified their existing development and commercialization agreement, according to a...

Company Profile

Business DescriptionPacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. The firm's products and services include PacBio sequel system, consumables, analytical software and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. View company web site for more details
Address1305 O'Brien Drive
Menlo Park, California 94025
Number of Employees401
Recent SEC Filing08/08/202210-Q
President, Chief Executive Officer & DirectorChristian O. Henry
Chief Operating OfficerMark David van Oene
Chief Financial OfficerSusan G. Kim
Chief Technology OfficerStephen W. Turner

Company Highlights

Price Open$8.69
Previous Close$8.79
52 Week Range$3.85 - 32.55
Market Capitalization$1.9 B
Shares Outstanding224.8 M
SectorHealth Technology
Next Earnings Announcement11/01/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.84
Beta vs. S&P 500N/A
Revenue$78.6 M
Net Profit Margin-147.39%
Return on Equity-26.99%

Analyst Ratings as of 01/04/2022

Consensus RecommendationConsensus Icon
Powered by Factset